Editorial: risky business. What do sufferers' perceptions of risk from interventions for irritable bowel syndrome really mean? Quigley EMM. Aliment Pharmacol Ther 2022;55:1218-1219.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Quigley EMM. Editorial: risky business. What do sufferers' perceptions of risk from interventions for irritable bowel syndrome really mean? Aliment Pharmacol Ther 2022;55:1218-1219.
PMID: 35429038